增长差异化因子15:从应激反应到慢性肝病的临床效用
1Department of Gastroenterology and Hepatology, Graduate School of Medicine, The University of Osaka, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Journal of gastroenterology
|December 23, 2025
概括
增长差异化因子15 (GDF15) 显示为慢性肝病的非侵入性生物标志物,独立于纤维化. 它有助于对肝细胞癌和其他并发症的风险进行分层,指导患者管理.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 生物标志物发现发现
- 在瘤学瘤学.
背景情况:
- 由于有效的抗病毒疗法,慢性肝病的治疗正在发展,但由于代谢功能障碍相关的脂肪性肝病 (MASLD) 面临挑战.
- 非常需要非侵入性生物标志物来分层风险并指导各种慢性肝病病因的管理.
- 增长分化因子15 (GDF15),是一种应激诱导性细胞因子,由于与疾病进展和结果的关联,它正在成为一个重要的生物标志物.
研究的目的:
- 评估生长分化因子15 (GDF15) 作为慢性肝病的预后生物标志物.
- 确定GDF15是否提供独立于肝纤维化的预后信息.
- 探索GDF15在风险分层和指导临床管理方面的潜力.
主要方法:
- 慢性肝病患者循环GDF15水平的分析.
- GDF15水平与疾病严重程度,肝细胞癌 (HCC) 风险,肝衰竭和死亡率的相关性.
- 评估GDF15与纤维化阶段和传统生物标志物的独立性.
主要成果:
- 血清GDF15水平升高始终与纤维化严重程度增加,HCC风险增加,肝衰竭和死亡率相关.
- GDF15集成了肝细胞和脑膜应激,捕捉了纤维化和标准分数之外的残留风险.
- GDF15显示出诊断效用,独立于肝纤维化阶段.
结论:
- GDF15是慢性肝病的有希望的非侵入性生物标志物,提供了超越纤维化症的预后价值.
- GDF15集成了多种压力路径,反映了肝损伤的全面形象.
- 需要进一步的研究来阐明GDF15的机制和精密医学中的治疗潜力.
相关概念视频
Liver Regeneration
4.2K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.2K
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Liver Physiology
3.4K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.4K
Regulation of Hematopoietic Stem Cells
3.9K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.9K
Cell Specific Gene Expression
16.2K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
16.2K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
157
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
157


